Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

~12 mi. (Halle (Saale), Germany, +140 more cities)

Universitaetsklinikum Halle ( Site 0213)

Hepatocellular Carcinoma

lenvatinib, +2 more drugs

chemotherapy, +2 more types

A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

~12 mi. (Halle (Saale), Germany, +142 more cities)

Universitaetsklinik und Polikl

del(11)(q10), +27 more biomarkers

Myelofibrosis

imetelstat, +1 more drug

targeted therapy

Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

~12 mi. (Halle (Saale), Germany, +228 more cities)

Krankenhaus Martha-Maria Halle-Doelau /ID# 205442

MET Expression

Non-Small Cell Lung Carcinoma

telisotuzumab vedotin

chemotherapy, +1 more type

A Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

~12 mi. (Halle (Saale), Germany, +16 more cities)

Site DE49001

FLT3 ITD

Acute Myeloid Leukemia

cytarabine, +3 more drugs

chemotherapy, +2 more types

Study in Patients With Chronic Leukemia, Where Previous Therapy Failed, and Who Will be Treated With Ponatinib as Second Line Therapy

~12 mi. (Halle (Saale), Germany, +9 more cities)

University Hospital

BCR-ABL1 Fusion, +1 more biomarker

Chronic Myeloid Leukemia

ponatinib

targeted therapy

A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)

~13 mi. (Niemberg, Germany, +93 more cities)

Klinikum Nuernberg Nord ( Site 1300)

Clear Cell Renal Cell Carcinoma

belzutifan, +1 more drug

targeted therapy

A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer

~30 mi. (Dessau, Germany, +144 more cities)

GSK Investigational Site

Endometrial Carcinoma

carboplatin, +3 more drugs

chemotherapy, +2 more types

Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer

~30 mi. (Dessau, Germany, +37 more cities)

Stadtisches Klinikum Dessau

ER Negative, +2 more biomarkers

Breast Carcinoma

ladiratuzumab vedotin, +1 more drug

chemotherapy, +2 more types

Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)

~37 mi. (Leipzig, Germany, +147 more cities)

Universitaetsklinik Leipzig ( Site 0456)

Cervical Adenocarcinoma, +2 more conditions

brachytherapy, +3 more drugs

chemotherapy, +2 more types

Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-7902-015/E7080-G000-321/LEAP-015)

~37 mi. (Leipzig, Germany, +131 more cities)

Universitaetsklinikum Leipzig ( Site 1211)

HER2 Negative

Adenocarcinoma of the Gastroesophageal Junction, +2 more conditions

CAPOX regimen, +3 more drugs

chemotherapy, +2 more types

A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (LEAP-010) (MK-7902-010)

~37 mi. (Leipzig, Germany, +127 more cities)

Universitätsklinikum Leipzig-Department for ENT ( Site 2106)

Hypopharyngeal Squamous Cell Carcinoma, +3 more conditions

lenvatinib, +1 more drug

immunotherapy, +1 more type

Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome

~37 mi. (Leipzig, Germany, +201 more cities)

Universitaetsklinikum Leipzig /ID# 221168

Myelodysplastic Syndromes

azacitidine, +1 more drug

chemotherapy